South Jordan, Utah-based Merit adds the latest delivery system to its growing electrophysiology (EP) and cardiac rhythm ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed ...

The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial’s ...

The analyst highlighted the company’s DurAVR technology as a standout in the transcatheter aortic valve replacement market. TD Cowen also began coverage with a Buy rating and a $15.00 price ...

The analyst highlighted the company’s DurAVR technology as a standout in the transcatheter aortic valve replacement market. TD (TSX:TD) Cowen also began coverage with a Buy rating and a $15.00 price ...

Get Instant Summarized Text (Gist) A new transcatheter valve, the Trilogy system, has demonstrated safety and efficacy in treating aortic regurgitation, with a one-year mortality rate of 8.1% ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Fusion energy start-up Marvel Fusion has raised €113mn in new funding as Germany steps up its efforts to ...

China is poised to start building the world’s first fusion-fission hybrid power plant, with the goal of generating 100 megawatts of continuous electricity and connecting to the grid by the end ...